Actively Recruiting
Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
Led by Centre Hospitalier Universitaire de Liege · Updated on 2025-08-22
300
Participants Needed
1
Research Sites
348 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire de Liege
Lead Sponsor
C
Centre Hospitalier Régional de la Citadelle
Collaborating Sponsor
AI-Summary
What this Trial Is About
The ActiLiège-Adult study is a prospective, longitudinal, observational study designed to collect natural history data on adult patients with neurological or metabolic diseases affecting movement. Conducted at the Centre de Référence Liégeois des Maladies Neuromusculaires in Liège, Belgium, the study will enroll 300 ambulant patients, including individuals with neuromuscular disorders and obesity. Using the Syde® wearable device, the study aims to continuously monitor motor function in real-life settings over a period of up to two years. The primary objective is to evaluate the utility of digital mobility outcomes, such as the 95th centile of stride velocity (SV95C), as reliable and objective endpoints for future clinical trials.
CONDITIONS
Official Title
Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to walk 10 meters without assistance
- Confirmed diagnosis based on standard methods for their disease
- Myotonic dystrophy type 1 and Charcot-Marie-Tooth patients must show sensitive or motor signs on exam
- Myasthenic patients must be seropositive and classified as MGFA class II to IV
- Patients with morbid obesity (BMI ≥ 35 at inclusion)
- Signed informed consent and willingness to follow study procedures
You will not qualify if you...
- Unable to walk
- Severe cognitive disorders limiting understanding of exercises
- Recent surgery or trauma to upper or lower limbs within 6 months
- Chronic or acute neurological, endocrine, infectious, allergic, or inflammatory disease within 3 weeks before inclusion
- Participation in an interventional clinical trial
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre de référence des maladies neuromusculaire, Centre Hospitalier Régional de la Citadelle
Liège, Belgium, 4000
Actively Recruiting
Research Team
N
Nicolas Bovy
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
8
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here